Enhancing rare tumor detection: A cross-modal generative adversarial network benchmark for data augmentation in cardiac, liver, and retinal imaging
Muhammad Umer Farooq , Danish Jamil , Saad Bin Jawaid
Eurasian Journal of Medicine and Oncology ›› 2026, Vol. 10 ›› Issue (3) : 025460482
Introduction: Rare pathologies in medical imaging suffer from severe data scarcity, leading to AI models with low sensitivity and high false-negative rates, resulting in missed diagnoses with potentially life-threatening consequences. Although generative adversarial networks (GANs) offer a promising solution by generating synthetic images, no empirically derived quality thresholds currently exist for safe clinical deployment.
Objective: To systematically evaluate DCGAN, WGAN-GP, and StyleGAN for generating clinically useful synthetic chest X-rays, focusing on false-negative reduction and establishing clinical quality thresholds.
Methods: Using the NIH Chest X-ray dataset (89,139 images; 14 pathologies), three GAN architectures were trained to augment underrepresented classes. Evaluation included quantitative metrics (FID and structure-specific SSIM), diagnostic performance across three datasets, blinded radiologist review (n= 5; 100 images per model), and failure analysis quantifying false-negative rates.
Results: StyleGAN outperformed alternatives (FID = 18.2 vs. DCGAN: 45.6; WGAN-GP: 23.4), achieved SSIM of 0.92 (vs. 0.78 and 0.85), and preserved lung patterns at 0.90 (vs. 0.74 and 0.82). Sensitivity increased from 79.5% to 94.2%, yielding approximately 10 additional early detections per 100 rare pathology cases. StyleGAN reduced false negatives for small nodules to 12% compared to 28% for DCGAN—a 16% absolute reduction, translating to 160 additional correct diagnoses per 1,000 high-risk screenings. Radiologists rated StyleGAN images 4.7/5 (vs. DCGAN: 2.8/5). This study proposes the first empirically derived clinical quality thresholds for synthetic chest X-rays: FID < 20, SSIM > 0.90, small-structure SSIM > 0.85, and radiologist score > 4.5/5. Only StyleGAN met all criteria.
Conclusion: High-quality GANs, particularly StyleGAN, significantly reduce false negatives and improve rare pathology detection. By directly linking synthetic image quality to measurable reductions in false negatives, this study establishes clinically actionable safety thresholds and provides a regulatory-aligned framework for responsible deployment of GAN-augmented medical imaging systems.
Generative adversarial networks / Medical imaging / Rare pathology / False-negative reduction / Clinical thresholds / StyleGAN / Chest X-ray / Data augmentation
| [1] |
|
| [2] |
World Health Organization. Cancer. World Health Organization. 2022. Accessed March 22, 2025. https://www.who.int/news-room/fact-sheets/detail/cancer |
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
/
| 〈 |
|
〉 |